Wiley Bros. Aintree Capital, LLC Teva Pharmaceutical Industries LTD Transaction History
Wiley Bros. Aintree Capital, LLC
- $9.13 Billion
- Q1 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 30,114 shares of TEVA stock, worth $494,471. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,114
Previous 30,526
1.35%
Holding current value
$494,471
Previous $672,000
31.25%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
651Shares Held
646MCall Options Held
22MPut Options Held
15.8M-
Black Rock Inc. New York, NY43MShares$706 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$641 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$621 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$620 Million8.62% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.33.4MShares$548 Million6.4% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...